Acquiring Company
Vivo Infusion
Acquired Company
CIVIC Infusion
Description
Vivo Infusion, a nationally recognized provider of accessible and affordable ambulatory infusion service announced today it has acquired CIVIC Infusion, a company dedicated to delivering safe, convenient, and affordable solutions for infusion patients in Connecticut and New York. With this acquisition, Vivo Infusion will advance to a combined 36 ambulatory infusion centers across nine states. In connection with the transaction, CIVIC’s co-founders Barry D. Stein, MD, and Robert M. Roteman, MD will join Vivo Infusion as Medical Directors. Financial terms of the transaction were not disclosed.
Quick answer
Vivo Infusion is acquiring CIVIC Infusion, announced January 31, 2023. Vivo Infusion is based in Lakewood, Colorado, United States.
- How much did Vivo Infusion pay for CIVIC Infusion?
- The deal value was not disclosed.
- What does Vivo Infusion do?
- Vivo Infusion is a leading provider of accessible, affordable, community-based infusion and injection care for patients suffering from compromised immune systems, infectious diseases, and other medical conditions.
- Where are Vivo Infusion and CIVIC Infusion based?
- Vivo Infusion is based in Lakewood, Colorado, United States.
- Who are the decision-makers at Vivo Infusion?
- Fundz holds 1 contact at Vivo Infusion. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Kymanox Acquires Eu Based Anteris Medical And Anteris Helvetia (February 2, 2023)
- Shockwave Medical Announces Agreement To Acquire Neovasc (January 17, 2023)
- Shockwave Medical To Acquire Neovasc (January 17, 2023)
- Cultivate(Md) Capital Funds Announces Portfolio Company Embody'S Acquisition By Zimmer Biomet Holdings, Inc. (January 10, 2023)
- Rhythm Pharmaceuticals Announces Acquisition Of Xinvento B.V. And Portfolio Of Investigational Therapeutics (February 27, 2023)
- Clarapath Acquires Crosscope And Combines Tissue Processing Robotics With Ai Powered Digital Pathology For Building The Lab Of The Future (February 27, 2023)
Who to call at Vivo Infusion, and when
When Vivo Infusion changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Vivo Infusion raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vivo Infusion, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vivo Infusion. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vivo Infusion makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired CIVIC Infusion?
CIVIC Infusion was acquired by Vivo Infusion, based in Lakewood. The deal was reported on January 31, 2023. Vivo Infusion is a leading provider of accessible, affordable, community-based infusion and injection care for patients suffering from compromised immune systems, infectious diseases, and other medical conditions. Vivo Infusion is privately held and operates in Biotechnology.
When did Vivo Infusion acquire CIVIC Infusion?
Vivo Infusion's acquisition of CIVIC Infusion was reported on January 31, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does CIVIC Infusion do?
CIVIC Infusion is dedicated to delivering safe, convenient, and affordable care for infusion patients. It is privately held, operating in Health Care.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.